跳至主要内容
临床试验/NCT05017350
NCT05017350招募中不适用

Hemostasis Using Radiofrequency Ablation for Track Bleeding After Liver Biopsy

Kyoung Doo Song2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
10
试验地点
2
主要终点
hemostasis rate

研究概览

简要总结

This study aims to evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding that has occurred after percutaneous biopsy of the liver.

详细描述

Purpose: To evaluate the usefulness of hemostasis using radiofrequency ablation for track bleeding after percutaneous liver biopsy.

Method:

  • Enroll patients who continue to bleed despite conservative treatment for track bleeding that has occurred after liver biopsy.
  • Radiofreqeuncy ablation: Under monitoring vital signs and controlling pain with intravenous agents, the electrode is inserted into the bleeding focus. The bleeding focus is ablated.
  • Hemostasis is evaluated by ultrasound (right after radiofrequency ablation), CT scan (after the radiofrequency ablation), and ultrasound (the day after radiofrequency ablation)
  • If hemostasis fails using radiofrequency ablation, transarterial hepatic embolization is performed immediately.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ultrasound guided percutaneous liver biopsy at Samsung Medical Center
  • Track bleeding after biopsy
  • Persistent track bleeding even after conservative management
  • Consent to this study

排除标准

  • Not consent to this study
  • <20 years old or >=80 years old
  • Contraindication to radiofrequency ablation
  • Radiofrequency ablation for track bleeding is not technically possible.
  • Unstable vital signs

结局指标

主要结局

hemostasis rate

时间窗: immediately after radiofrequency ablation

success rate of hemostasis using radiofrequency ablation on CT taken after radiofrequency ablation

次要结局

  • complication rate(immediately after radiofrequency ablation)

研究者

发起方
Kyoung Doo Song
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kyoung Doo Song

Associate Professor

Samsung Medical Center

研究点 (2)

Loading locations...

相似试验